Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, announced a research collaboration with Genentech, a member of the Roche Group, to discover and develop multiple therapeutic bispecific antibody programs in oncology. Under the collaboration, Earendil Labs will lead antibody disco…
RAD Technology Medical Systems (RAD), a provider of innovative Modular Medical Facilities, is pleased to announce a collaboration with Centro Científico Tecnológico de Valparaíso (CCTVal), an applied research and technology center of Universidad Técnica Federico Santa María (UTSM) in Chile to support the sale and intr…
Recipharm, a leading global contract development and manufacturing organisation (CDMO), and CanVirex, a Swiss biotechnology company developing next-generation oncolytic virus immunotherapies, announced a process development collaboration to support the scale-up of CanVirex's Vero cell/measles virus manufacturing platf…
Claros Technologies (Claros), a global leader in permanent PFAS destruction technology, today announced the successful completion of a commercial-scale pilot of its ClarosTechUV system at the flagship Swiss manufacturing campus of Bachem AG (Bachem) in Bubendorf, Switzerland. Bachem is one of the world's leading manuf…
AbbVie and Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and development platform,announced a multi-year collaboration to accelerate the discovery and development of small molecule therapies with first-in-class and best-in-class potential acros…
mAbxience, a majority-owned company of Fresenius with partial ownership from Insud Pharma; and Sandoz , the global leader in affordable medicines, announced a licensing, development, manufacturing and commercialization agreement for an emicizumab biosimilar candidate. The collaboration agreement combines mAbxience's …
Telix Pharmaceuticals Limited announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE, a global leader in radioisotope production and radiopharmaceutical development. The merger will further strengthen Telix's leadership as a vertically integrated radiopharmaceutical com…
Jazz Pharmaceuticals plc announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. Jazz completed the acquisition of Actio Biosciences through the merger of Knight Acquisition Corp. (the "Merger Sub"), a D…
Jaguar LAA, Inc, a privately held medical device company announced the acquisition of assets related to the Laminar program, focused on addressing the left atrial appendage in patients with non-valvular atrial fibrillation ("AFib"), from Johnson & Johnson. The transaction brings key Laminar program assets togethe…
Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd., a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading health…
Page 1 of 40